Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry Kenakin

Showing results (41-50 of 113) with videos related to

Pageof 12
Sort By:
Journal of Receptor and Signal Transduction Research|March 10, 2011
The extremely active area of catecholamine pharmacologyTerry Kenakin
Current Protocols in Pharmacology|February 2, 2012
Overview of receptor interactions of agonists and antagonistsTerry Kenakin
Molecular Interventions|August 12, 2004
Allosteric modulators: the new generation of receptor antagonistTerry Kenakin
Journal of Receptor and Signal Transduction Research|July 8, 2009
Interrogating 7TM receptors: does texture in the question yield greater texture in the answer?Terry Kenakin
Trends in Pharmacological Sciences|July 17, 2007
Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptorsTerry Kenakin
Nature Biotechnology|September 11, 2010
A holistic view of GPCR signalingTerry Kenakin
Journal of Receptor and Signal Transduction Research|September 22, 2007
Allosteric agonist modulatorsTerry Kenakin
Expert Opinion on Drug Discovery|March 19, 2013
Collateral efficacy as a pharmacological problem applied to new drug discoveryTerry Kenakin
Handbook of Experimental Pharmacology|December 3, 2013
Quantifying biased β-arrestin signalingTerry Kenakin
Current Opinion in Structural Biology|April 4, 2026
Therapeutic implications of target residence timeTerry Kenakin
Pageof 12

Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
Journal of Receptor and Signal Transduction Research|March 10, 2011
The extremely active area of catecholamine pharmacologyTerry Kenakin
Current Protocols in Pharmacology|February 2, 2012
Overview of receptor interactions of agonists and antagonistsTerry Kenakin
Molecular Interventions|August 12, 2004
Allosteric modulators: the new generation of receptor antagonistTerry Kenakin
Journal of Receptor and Signal Transduction Research|July 8, 2009
Interrogating 7TM receptors: does texture in the question yield greater texture in the answer?Terry Kenakin
Trends in Pharmacological Sciences|July 17, 2007
Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptorsTerry Kenakin
Nature Biotechnology|September 11, 2010
A holistic view of GPCR signalingTerry Kenakin
Journal of Receptor and Signal Transduction Research|September 22, 2007
Allosteric agonist modulatorsTerry Kenakin
Expert Opinion on Drug Discovery|March 19, 2013
Collateral efficacy as a pharmacological problem applied to new drug discoveryTerry Kenakin
Handbook of Experimental Pharmacology|December 3, 2013
Quantifying biased β-arrestin signalingTerry Kenakin
Current Opinion in Structural Biology|April 4, 2026
Therapeutic implications of target residence timeTerry Kenakin
Pageof 12